FDA approves SOMA 250 mg

The FDA recently approved a 250mg Soma® tablet manufactured by MedPointe Pharmaceuticals as a new recommended dose for the treatment of painful musculoskeletal problems such as backache. The drug is not new, in fact it has been around for nearly 50 years, first receiving FDA approval in 1959. The same drug was available at one time in a 250mg capsule but was discontinued.

As a pharmaceutical consultant working in pain management area, I think lower dose will offer similar efficacy as Soma 350 mg but with a more favorable tolerability profile. Last week, Last week, The Food and Drug Administration (FDA) have approved 250 mg (lower dose) of Soma (carisoprodol) for treatment of painful musculoskeletal conditions such as backache. As a pharmaceutical consultant working...

Soma has been around for many years. Now we have a new strength? Probably because there is no generic available on the 250mg.

- Soma is highly addictive - it has no proven benefit - there are many non-addictive drugs which do what Soma claims to do